Atlas Trials

Impact of Intranasal Insulin on Sympathetic Activity and Cerebral Vasodilation

Clinical trial NCT05153395 · SUSPENDED

Trial details

NCT number
NCT05153395
Sponsor
University of Missouri-Columbia
Status
SUSPENDED
Phase
Early Phase 1
Study type
INTERVENTIONAL
HealthyVasodilationInsulin ResistanceAutonomic DysfunctionObesity
Start date
2021-12-01
Primary completion
2027-06-01
Enrollment
65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.